Randomized Intravenous Tezosentan Study - RITZ-4

Description:

The goal of the Randomized Intravenous TeZosentan (RITZ-4) study was to compare tezosentan, a nonselective endothelin antagonist, versus placebo in patients with acute decompensated heart failure (HF) associated with acute coronary syndrome (ACS).